The olfactory bulbectomized (OB) rat has been proposed as an animal mo
del of depression The following behavioural changes have been observed
following bilateral olfactory bulbectomy: hyperactivity in an enclose
d arena, such as the open field; enhanced nocturnal hyperactivity in a
24-hr home cage activity monitor; deficits in memory, as shown by pas
sive avoidance behaviour and in the Morris maze and the 8-arm radial m
aze; increased open arm entries in the elevated plus-maze; and changes
in food motivated and conditioned taste aversion behaviour. Alteratio
ns in the noradrenergic, serotonergic, cholinergic, gamma-aminobutyric
acid (GABA)ergic and glutamatergic neurotransmitter systems are also
associated with olfactory bulbectomy. The variety of immune changes fo
llowing olfactory bulbectomy includes reduced neutrophil phagocytosis,
lymphocyte mitogenesis, lymphocyte number and negative acute phase pr
oteins, increased leucocyte adhesiveness/aggregation, monocyte phagocy
tosis, neutrophil number and positive acute phase proteins. An enhance
d nocturnal secretion of corticosterone is observed in OB rats, which
is normally suppressed by dexamethasone The most commonly employed beh
avioural indicator of antidepressant activity is attenuation of the OB
-related hyperactivity in the open-field. However, many of the other b
ehavioural, neurotransmitter and immune changes have been shown to be
attenuated by chronic (but not acute) antidepressant treatment. Tricyc
lic antidepressants (amitriptyline, desipramine), atypical agents (mia
nserin), selective serotonin reuptake inhibitors (paroxetine, sertrali
ne, fluvoxamine), reversible inhibitors of monoamine oxidase A (moclob
emide), as well as putative antidepressants such as 5-hydroxytryptamin
e(1A) agonists (zalospirone, ipsapirone), noncompetitive N-methyl-D-as
partate antagonists (MK-801) and triazolobenzodiazepines (alprazolam,
adinazolam), have demonstrated antidepressant-like activity in this mo
del. As many of the changes exhibited by the OB rat are qualitatively
similar to those observed in depressed patients, it may be concluded t
hat the OB rat is a model of depression and not just a means whereby p
utative antidepressants may be tested. (C) 1997 Elsevier Science Inc.